Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10817)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2014 (publication date) through Jan 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Samonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, Papiamonis N, Fragaki M, Matrella E, Tzardi M, Kouroumalis EA. Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol 2014; 6(7): 504-512 [PMID: 25068002 DOI: 10.4254/wjh.v6.i7.504] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i7/504.htm |
| Number | Citing Articles |
| 1 |
Zachary R. Bergman, Greg J. Beilman. The Acute Management of Surgical Disease. 2022; : 487 doi: 10.1007/978-3-031-07881-1_35
|
| 2 |
Saad Saffo, Guadalupe Garcia‐Tsao, Tamar Taddei. SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension. Journal of Diabetes 2021; 13(3): 265 doi: 10.1111/1753-0407.13136
|
| 3 |
Maaike Biewenga, Xavier P.D.M.J. Verhelst, Martine A.M.C. Baven‐Pronk, Hein Putter, Aad P. van den Berg, Karin C.M.J. van Nieuwkerk, Henk R. van Buuren, Gerd Bouma, Ynte S. de Boer, Cedric Simoen, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe van Steenkiste, Hans van Vlierberghe, Adriaan J. van der Meer, Frederik Nevens, Bart van Hoek. Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1. United European Gastroenterology Journal 2021; 9(6): 662 doi: 10.1002/ueg2.12112
|
| 4 |
Ankur Srivastava, Simcha Jong, Anna Gola, Ruth Gailer, Sarah Morgan, Karen Sennett, Sudeep Tanwar, Elena Pizzo, James O’Beirne, Emmanuel Tsochatzis, Julie Parkes, William Rosenberg. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1039-4
|
| 5 |
An-Hsun Chou, Ching-Chang Chen, Yu-Sheng Lin, Ming-Shyan Lin, Victor Chien-Chia Wu, Pei-Chi Ting, Shao-Wei Chen. A population-based analysis of endovascular aortic stent graft therapy in patients with liver cirrhosis. Journal of Vascular Surgery 2019; 69(5): 1395 doi: 10.1016/j.jvs.2018.06.225
|
| 6 |
Georgios N. Kalambokis, Nikolleta Chouliara, Ilias Tsiakas, Sempastien Filippas-Ntekuan, Maria Christaki, Grigorios Despotis, Haralampos Milionis. Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patients. European Journal of Gastroenterology & Hepatology 2024; 36(1): 89 doi: 10.1097/MEG.0000000000002648
|
| 7 |
Marcelo Kugelmas, Michelle Loftus, Emily J Owen, Hani Wadei, Sammy Saab. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis. American Journal of Health-System Pharmacy 2023; 80(13): 806 doi: 10.1093/ajhp/zxad070
|
| 8 |
Winston E. Abara, P. Spradling, Y. Zhong, A. Moorman, E. H. Teshale, L. Rupp, S. C. Gordon, M. Schmidt, J. A. Boscarino, Y. G. Daida, S. D. Holmberg. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis. Journal of Gastrointestinal Cancer 2020; 51(2): 461 doi: 10.1007/s12029-019-00255-4
|
| 9 |
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
|
| 10 |
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosis. Academic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
|
| 11 |
Elena Curakova Ristovska. Portal Hypertension - Recent Advances. 2021; doi: 10.5772/intechopen.96172
|
| 12 |
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren, Hanne Prytz. Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long‐term follow‐up study of 1317 patients. Alimentary Pharmacology & Therapeutics 2019; 49(11): 1421 doi: 10.1111/apt.15255
|
| 13 |
Sumeet K. Asrani, Lauren Hall, Vikrant Reddy, Gerald Ogola, Manhal Izzy. Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study. American Journal of Gastroenterology 2022; 117(12): 2009 doi: 10.14309/ajg.0000000000001909
|
| 14 |
Amit G. Singal, Jagpreet Chhatwal, Neehar Parikh, Elliot Tapper. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis. Liver Cancer 2024; : 1 doi: 10.1159/000539895
|
| 15 |
Lindsay A Sobotka, Carleen Spitzer, Alice Hinton, Anthony Michaels, A James Hanje, Khalid Mumtaz, Lanla F Conteh. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30‐day hospital readmission. Journal of Gastroenterology and Hepatology 2020; 35(4): 641 doi: 10.1111/jgh.14842
|
| 16 |
Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska. Survival in Patients with Liver Cirrhosis: A Prospective Study. PRILOZI 2023; 44(3): 41 doi: 10.2478/prilozi-2023-0045
|
| 17 |
Jingbiao Chen, Peng Xu, Kyle Kalutkiewicz, Yiyang Sheng, Fatima Warsame, Mahmoud-Adam Tahboub-Amawi, Jiahui Li, Jin Wang, Sudhakar K. Venkatesh, Richard L. Ehman, Vijay H. Shah, Douglas A. Simonetto, Meng Yin. Liver stiffness measurement by magnetic resonance elastography predicts cirrhosis and decompensation in alcohol-related liver disease. Abdominal Radiology 2024; 49(7): 2231 doi: 10.1007/s00261-024-04479-2
|
| 18 |
Lindsay A Sobotka, Khalid Mumtaz, Alice Hinton, Sean G Kelly, Lanla F Conteh, Anthony J Michaels, A. James Hanje, Michael R Wellner. Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis. Annals of Hepatology 2021; 23: 100280 doi: 10.1016/j.aohep.2020.10.008
|
| 19 |
Hong Zhao, Qi Wang, Changling Luo, Ligai Liu, Wen Xie, Xingshun Qi. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/9609731
|
| 20 |
Luka Vranić, Tin Nadarevic, Davor Štimac, Mirella Fraquelli, Cristina Manzotti, Giovanni Casazza, Agostino Colli. Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography-based techniques in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2022; 2022(8) doi: 10.1002/14651858.CD015415
|
| 21 |
Balakrishnan Bini, B. Vijayalakshmi, K. T. Shenoy, Joseph Kurian Mukkadan. Etiological Spectrum, Epidemiological Characteristics in Compensated and Decompensated Cirrhosis at First Presentation. Asian Journal of Pharmaceutical Research and Health Care 2023; 15(4): 329 doi: 10.4103/ajprhc.ajprhc_97_23
|
| 22 |
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, Stavros P. Papadakos, Kalliopi Kotsa, Georgios Germanidis. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(1): 102935 doi: 10.1016/j.dsx.2023.102935
|
| 23 |
Elsebeth Elmstrøm Jensen, Rikke Baltzer, Susanne Helle Bjerg, Palle Bager. Supportive care in end-stage liver disease: a clinical review. Gastrointestinal Nursing 2018; 16(6): 38 doi: 10.12968/gasn.2018.16.6.38
|
| 24 |
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
|
| 25 |
Behailu Terefe Tesfaye, Esayas Kebede Gudina, Dula Dessalegn Bosho, Teshale Ayele Mega, Chiara Lazzeri. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia. PLOS ONE 2019; 14(8): e0221806 doi: 10.1371/journal.pone.0221806
|
| 26 |
Khaled Al-Smadi, Ammar Qureshi, Michelle Buitrago, Besher Ashouri, Zeid Kayali, Dirk Uhlmann. Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study. International Journal of Hepatology 2024; 2024(1) doi: 10.1155/2024/5852680
|
| 27 |
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clinical and Molecular Hepatology 2020; 26(4): 444 doi: 10.3350/cmh.2020.0022
|
| 28 |
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. Journal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
|
| 29 |
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
|
| 30 |
E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk‐Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont. Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver disease. Journal of Viral Hepatitis 2017; 24(4): 287 doi: 10.1111/jvh.12645
|
| 31 |
Gennaro D’Amico, Giovanni Perricone. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?. Current Hepatology Reports 2019; 18(2): 144 doi: 10.1007/s11901-019-00473-1
|
| 32 |
Jorge Simon, Alberto Ouro, Lolia Ala-Ibanibo, Natalia Presa, Teresa Cardoso Delgado, María Luz Martínez-Chantar. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. International Journal of Molecular Sciences 2019; 21(1): 40 doi: 10.3390/ijms21010040
|
| 33 |
Sehrish Kamal, Muhammad Ali Khan, Ankur Seth, George Cholankeril, Deepansh Gupta, Utkarsh Singh, Faisal Kamal, Colin W Howden, Christopher Stave, Satheesh Nair, Sanjaya K Satapathy, Aijaz Ahmed. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2017; 112(10): 1495 doi: 10.1038/ajg.2017.170
|
| 34 |
Marlene López-Sánchez, Aleida Bautista-Santos, María del Pilar Milke-García, Aldo Allende-López, Rosalba Moreno-Alcántar, Segundo Morán. Nutritional status and incidence of hepatocellular carcinoma in patients with compensated liver cirrhosis. Archives of Medical Research 2025; 56(3): 103127 doi: 10.1016/j.arcmed.2024.103127
|
| 35 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 36 |
Jonathan N. Thomas, Joanna Roopkumar, Tushar Patel, Matias A. Avila. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study. PLOS ONE 2021; 16(11): e0260098 doi: 10.1371/journal.pone.0260098
|
| 37 |
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, A James Hanje, Anthony J Michaels, Lanla F Conteh, Alice Hinton, Ashraf El-Hinnawi, Khalid Mumtaz. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission. World Journal of Hepatology 2018; 10(6): 425-432 doi: 10.4254/wjh.v10.i6.425
|
| 38 |
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
|
| 39 |
Hamza Tahir, Manisha Verma, Bakhtawer Siraj, Richard S. Kalman. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond. Current Treatment Options in Gastroenterology 2024; 22(4): 218 doi: 10.1007/s11938-024-00461-5
|
| 40 |
Sachiyo Igata, Yuko Kono, Thomas Van Houten, Calvin T. Hang, Bruno R. Cotter, Monet G. Strachan, Nagisa Morikawa, Anthony N. DeMaria. Role of Quantitation of Saline Bubble Studies in Patients with Liver Cirrhosis. Ultrasound in Medicine & Biology 2023; 49(8): 1804 doi: 10.1016/j.ultrasmedbio.2023.04.003
|
| 41 |
Abdolamir Allameh, Reyhaneh Niayesh-Mehr, Azadeh Aliarab, Giada Sebastiani, Kostas Pantopoulos. Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants 2023; 12(9): 1653 doi: 10.3390/antiox12091653
|
| 42 |
Revanth Kalluru, Sai Gadde, Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, Swathi priya Cherukuri. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart. Cureus 2022; doi: 10.7759/cureus.27969
|
| 43 |
Huttakan Navadurong, Kessarin Thanapirom, Salisa Wejnaruemarn, Thaninee Prasoppokakorn, Roongruedee Chaiteerakij, Piyawat Komolmit, Sombat Treeprasertsuk. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World Journal of Gastroenterology 2023; 29(32): 4873-4882 doi: 10.3748/wjg.v29.i32.4873
Abstract(735) |
Core Tip(611) |
Full Article(HTML)(2170)
|
Full Article with Cover (PDF)-1072K(105)
|
Full Article (Word)-315K(37)
|
Audio-540K(5)
|
Peer-Review Report-256K(51)
|
Answering Reviewers-202K(52)
|
Full Article (PDF)-824K(192)
|
Full Article (XML)-97K(58)
|
Times Cited (6)
|
Total Visits (6444)
|
Open
|
| 44 |
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash. Compensated liver cirrhosis: Natural course and disease-modifying strategies. World Journal of Methodology 2023; 13(4): 179-193 doi: 10.5662/wjm.v13.i4.179
Abstract(518) |
Core Tip(493) |
Full Article(HTML)(5523)
|
Full Article with Cover (PDF)-904K(145)
|
Full Article (Word)-330K(66)
|
Audio-691K(11)
|
Peer-Review Report-358K(76)
|
Answering Reviewers-126K(98)
|
Full Article (PDF)-694K(374)
|
Full Article (XML)-311K(84)
|
Times Cited (9)
|
Total Visits (9066)
|
Open
|
| 45 |
Suzanna Fitzpatrick, Hazel Dhates Asunio Domingo, Sarah Merrill Finke. The Care of the Decompensated Cirrhotic Patient. The Journal for Nurse Practitioners 2017; 13(4): 256 doi: 10.1016/j.nurpra.2016.11.026
|
| 46 |
Amoako Duah, Adwoa Agyei-Nkansah, Foster Osei-Poku, Francisca Duah, Bright Peprah Addo, Isabelle Chemin. Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in Ghana. PLOS ONE 2021; 16(6): e0253759 doi: 10.1371/journal.pone.0253759
|
| 47 |
Ya-Chun Chang, Ying-Tang Fang, Hung-Cheng Chen, Chiung-Yu Lin, Yu-Ping Chang, Yi-Hsuan Tsai, Yu-Mu Chen, Kuo-Tung Huang, Huang-Chih Chang, Chin-Chou Wang, Meng-Chih Lin, Wen-Feng Fang. The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis. Journal of Clinical Medicine 2022; 11(6): 1629 doi: 10.3390/jcm11061629
|